SMAD9 and non-small cell lung carcinoma: Taken together, our data suggested that downregulated miR-744 in NSCLC cell-derived EVs enhanced the expression of SUV39H1, which then suppressed BMP4 expression by inhibiting Smad9, in NSCLC cells.